Dialysis; Complications
53
17
19
20
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.7%
3 terminated out of 53 trials
87.0%
+0.5% vs benchmark
8%
4 trials in Phase 3/4
15%
3 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (53)
Safely Disconnect From the Dialysis Machine in an Emergency Situation
Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Serum Magnesium Levels
LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM)
WISDOM UK: Low Dose-intensity Versus Standard Dose-intensity CRRT in Critically Ill Patients
Access Cannulation Trial II
Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
Timing of Renal Replacement Therapy in the Critically Ill Patients
Restrictive Versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
Effects of Short Term Creatine Supplementation in Hemodialysis Patients
Assessment of Thyroid Dysfunction in Patients Undergoing Haemodialysis at Sohag University Hospital
PRevEnting FracturEs in REnal Disease - 1
Dialysis Access Monitoring Using a Digital Stethoscope-Based Deep Learning System
Effect of Low Versus High Dialysate Sodium Concentration During Hemodialysis on Dialysis Recovery Time
ULtrafiltration-Rate Induced CArdiac Strain (ULRICA) - Study
Plasma Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in CKD Dialysis Patients
SARS-COV-2 Screening in Dialysis Facilities
Comparison of Three Types of Distal Arteriovenous Fistulas: SBAVF, RCAVF, and RCAVF With Venous Branch Patch.
Sodium Accumulation Study in Haemodialysis: Brain Study
The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study